AHRQ Releases Toolkit for Reducing CAUTIs in Hospitals

The Agency for Healthcare Research and Quality (AHRQ) released a new toolkit to help clinical teams reduce catheter-associated urinary tract infections (CAUTIs). Developed for clinicians by clinicians, the Toolkit for Reducing Catheter-Associated Urinary Tract Infections (CAUTIs) helps health care professionals prevent CAUTIs in patients by following clinical best practices and creating a culture of safety.

SUNA and AUA Develop Joint Statement on Intravesical Administration of Therapeutic Medication

SUNA and the American Urological Association (AUA) developed a joint Statement of Practice on Intravesical Administration of Therapeutic Medication. The purpose of the statement is to define the performance guidelines surrounding the instillation of intravesical cytotoxic, immunotherapeutic, and/or therapeutic drugs via sterile technique catheterization for patients with non-muscle invasive bladder cancer (urothelial carcinoma) or interstitial cystitis/bladder pain syndrome.

Joint Statement on Intravesical Administration of Therapeutic Medication

SUNA and the American Urological Association (AUA) developed a joint Statement of Practice on Intravesical Administration of Therapeutic Medication. The purpose of the statement is to define the performance guidelines surrounding the instillation of intravesical cytotoxic, immunotherapeutic, and/or therapeutic drugs via sterile technique catheterization for patients with non-muscle invasive bladder cancer (urothelial carcinoma) or interstitial cystitis/bladder pain syndrome.

Download the Statement

Pages